PAVmed Inc. 8-K

What Happened

• PAVmed Inc. announced it received a notification from the Nasdaq Listing Qualifications department on January 21, 2026 stating the company had regained compliance with the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). Nasdaq determined the company’s closing bid price was $1.00 or greater from January 2, 2026 through January 19, 2026.
• The company had previously been notified on January 23, 2025 that its closing bid price had been below $1.00 for the prior 30 consecutive business days (through January 22, 2025).

Key Details

• Date of Nasdaq compliance notice: January 21, 2026.
• Period Nasdaq found in compliance: closing bid $1.00+ from January 2, 2026 to January 19, 2026.
• Prior deficiency notice received: January 23, 2025 (30 consecutive business days below $1.00 through January 22, 2025).
• Filing type: Form 8-K reporting Other Events (Item 8.01).

Why It Matters

• Regaining compliance means PAVmed remains listed on the Nasdaq Capital Market and avoids potential delisting actions tied to the $1 minimum bid rule. That preserves liquidity and access to public capital for the company.
• Investors should note this confirms a recent recovery in PAVmed’s stock price to at least $1.00 for the referenced period, but continued compliance depends on future share price performance.